alcohol and drug use disorders · >14 drinks in one week for men) [criteria previous slide] cage...
TRANSCRIPT
1
Alcohol and Drug Use Disorders
Brian Fuehrlein MD PhD
Director Psychiatric Emergency Room VA
Connecticut and Assistant Professor of
Psychiatry Yale University
2
Brian Fuehrlein Disclosures
I have no financial relationships to disclose
The contents of this activity may include discussion of off label or investigative drug uses The
faculty is aware that is their responsibility to disclose this information
3
Planning Committee Disclosures
AAAP aims to provide educational information that is balanced independent objective and free of bias
and based on evidence In order to resolve any identified Conflicts of Interest disclosure information from
all planners faculty and anyone in the position to control content is provided during the planning process
to ensure resolution of any identified conflicts This disclosure information is listed below
The following developers and planning committee members have reported that they have no
commercial relationships relevant to the content of this module to disclose PCSS-MAT lead
contributors Frances Levin MD and Adam Bisaga MD AAAP CMECPD Committee Members Dean
Krahn MD Kevin Sevarino MD PhD Tim Fong MD Tom Kosten MD Joji Suzuki MD and AAAP
Staff Kathryn Cates-Wessel Miriam Giles Carol Johnson and Justina Pereira
All faculty have been advised that any recommendations involving clinical medicine must be based on
evidence that is accepted within the profession of medicine as adequate justification for their indications
and contraindications in the care of patients All scientific research referred to reported or used in the
presentation must conform to the generally accepted standards of experimental design data collection
and analysis The content of this CME activity has been reviewed and the committee determined the
presentation is balanced independent and free of any commercial bias Speakers will inform the learners
if their presentation will include discussion of unlabeledinvestigational use of commercial products
4
Target Audience
The overarching goal of PCSS-MAT is to make
available the most effective medication-assisted
treatments to serve patients in a variety of settings
including primary care psychiatric care and pain
management settings
5
Educational Objectives
At the conclusion of this activity participants should be able to
Describe alcohol use disorder definitions and epidemiology
Recognize the symptoms time course and treatment for alcohol withdrawal
Describe key concepts in other drug use disorders
Define basic information on urine drug testing
6
Alcohol Use Disorder
Centers for Disease Control and Prevention (CDC) Alcohol-Related Disease Impact (ARDI)
Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey
on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1
Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Alcohol use disorder is highly prevalent highly comorbid disabling and often goes untreated
12-month and lifetime prevalence of AUD is 139 and 291 respectively
Only 198 of those with an AUD were ever treated
AUD is significantly associated with MDD bipolar 1 ASPD and borderline PD and also with panic disorder and generalized anxiety disorder
Alcohol leads to approximately 88000 deaths and 25 million years of potential life lost each year in the US
7
Clinical Presentation
Steve presents to clinic for a
routine exam
Steve reports doing well with no
complaints
Steve reports drinking ldquo1-2 drinksrdquo
before bed a few nights each week
Steversquos wife reports that he actually drinks
a fifth of vodka nearly every night
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
2
Brian Fuehrlein Disclosures
I have no financial relationships to disclose
The contents of this activity may include discussion of off label or investigative drug uses The
faculty is aware that is their responsibility to disclose this information
3
Planning Committee Disclosures
AAAP aims to provide educational information that is balanced independent objective and free of bias
and based on evidence In order to resolve any identified Conflicts of Interest disclosure information from
all planners faculty and anyone in the position to control content is provided during the planning process
to ensure resolution of any identified conflicts This disclosure information is listed below
The following developers and planning committee members have reported that they have no
commercial relationships relevant to the content of this module to disclose PCSS-MAT lead
contributors Frances Levin MD and Adam Bisaga MD AAAP CMECPD Committee Members Dean
Krahn MD Kevin Sevarino MD PhD Tim Fong MD Tom Kosten MD Joji Suzuki MD and AAAP
Staff Kathryn Cates-Wessel Miriam Giles Carol Johnson and Justina Pereira
All faculty have been advised that any recommendations involving clinical medicine must be based on
evidence that is accepted within the profession of medicine as adequate justification for their indications
and contraindications in the care of patients All scientific research referred to reported or used in the
presentation must conform to the generally accepted standards of experimental design data collection
and analysis The content of this CME activity has been reviewed and the committee determined the
presentation is balanced independent and free of any commercial bias Speakers will inform the learners
if their presentation will include discussion of unlabeledinvestigational use of commercial products
4
Target Audience
The overarching goal of PCSS-MAT is to make
available the most effective medication-assisted
treatments to serve patients in a variety of settings
including primary care psychiatric care and pain
management settings
5
Educational Objectives
At the conclusion of this activity participants should be able to
Describe alcohol use disorder definitions and epidemiology
Recognize the symptoms time course and treatment for alcohol withdrawal
Describe key concepts in other drug use disorders
Define basic information on urine drug testing
6
Alcohol Use Disorder
Centers for Disease Control and Prevention (CDC) Alcohol-Related Disease Impact (ARDI)
Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey
on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1
Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Alcohol use disorder is highly prevalent highly comorbid disabling and often goes untreated
12-month and lifetime prevalence of AUD is 139 and 291 respectively
Only 198 of those with an AUD were ever treated
AUD is significantly associated with MDD bipolar 1 ASPD and borderline PD and also with panic disorder and generalized anxiety disorder
Alcohol leads to approximately 88000 deaths and 25 million years of potential life lost each year in the US
7
Clinical Presentation
Steve presents to clinic for a
routine exam
Steve reports doing well with no
complaints
Steve reports drinking ldquo1-2 drinksrdquo
before bed a few nights each week
Steversquos wife reports that he actually drinks
a fifth of vodka nearly every night
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
3
Planning Committee Disclosures
AAAP aims to provide educational information that is balanced independent objective and free of bias
and based on evidence In order to resolve any identified Conflicts of Interest disclosure information from
all planners faculty and anyone in the position to control content is provided during the planning process
to ensure resolution of any identified conflicts This disclosure information is listed below
The following developers and planning committee members have reported that they have no
commercial relationships relevant to the content of this module to disclose PCSS-MAT lead
contributors Frances Levin MD and Adam Bisaga MD AAAP CMECPD Committee Members Dean
Krahn MD Kevin Sevarino MD PhD Tim Fong MD Tom Kosten MD Joji Suzuki MD and AAAP
Staff Kathryn Cates-Wessel Miriam Giles Carol Johnson and Justina Pereira
All faculty have been advised that any recommendations involving clinical medicine must be based on
evidence that is accepted within the profession of medicine as adequate justification for their indications
and contraindications in the care of patients All scientific research referred to reported or used in the
presentation must conform to the generally accepted standards of experimental design data collection
and analysis The content of this CME activity has been reviewed and the committee determined the
presentation is balanced independent and free of any commercial bias Speakers will inform the learners
if their presentation will include discussion of unlabeledinvestigational use of commercial products
4
Target Audience
The overarching goal of PCSS-MAT is to make
available the most effective medication-assisted
treatments to serve patients in a variety of settings
including primary care psychiatric care and pain
management settings
5
Educational Objectives
At the conclusion of this activity participants should be able to
Describe alcohol use disorder definitions and epidemiology
Recognize the symptoms time course and treatment for alcohol withdrawal
Describe key concepts in other drug use disorders
Define basic information on urine drug testing
6
Alcohol Use Disorder
Centers for Disease Control and Prevention (CDC) Alcohol-Related Disease Impact (ARDI)
Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey
on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1
Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Alcohol use disorder is highly prevalent highly comorbid disabling and often goes untreated
12-month and lifetime prevalence of AUD is 139 and 291 respectively
Only 198 of those with an AUD were ever treated
AUD is significantly associated with MDD bipolar 1 ASPD and borderline PD and also with panic disorder and generalized anxiety disorder
Alcohol leads to approximately 88000 deaths and 25 million years of potential life lost each year in the US
7
Clinical Presentation
Steve presents to clinic for a
routine exam
Steve reports doing well with no
complaints
Steve reports drinking ldquo1-2 drinksrdquo
before bed a few nights each week
Steversquos wife reports that he actually drinks
a fifth of vodka nearly every night
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
4
Target Audience
The overarching goal of PCSS-MAT is to make
available the most effective medication-assisted
treatments to serve patients in a variety of settings
including primary care psychiatric care and pain
management settings
5
Educational Objectives
At the conclusion of this activity participants should be able to
Describe alcohol use disorder definitions and epidemiology
Recognize the symptoms time course and treatment for alcohol withdrawal
Describe key concepts in other drug use disorders
Define basic information on urine drug testing
6
Alcohol Use Disorder
Centers for Disease Control and Prevention (CDC) Alcohol-Related Disease Impact (ARDI)
Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey
on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1
Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Alcohol use disorder is highly prevalent highly comorbid disabling and often goes untreated
12-month and lifetime prevalence of AUD is 139 and 291 respectively
Only 198 of those with an AUD were ever treated
AUD is significantly associated with MDD bipolar 1 ASPD and borderline PD and also with panic disorder and generalized anxiety disorder
Alcohol leads to approximately 88000 deaths and 25 million years of potential life lost each year in the US
7
Clinical Presentation
Steve presents to clinic for a
routine exam
Steve reports doing well with no
complaints
Steve reports drinking ldquo1-2 drinksrdquo
before bed a few nights each week
Steversquos wife reports that he actually drinks
a fifth of vodka nearly every night
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
5
Educational Objectives
At the conclusion of this activity participants should be able to
Describe alcohol use disorder definitions and epidemiology
Recognize the symptoms time course and treatment for alcohol withdrawal
Describe key concepts in other drug use disorders
Define basic information on urine drug testing
6
Alcohol Use Disorder
Centers for Disease Control and Prevention (CDC) Alcohol-Related Disease Impact (ARDI)
Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey
on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1
Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Alcohol use disorder is highly prevalent highly comorbid disabling and often goes untreated
12-month and lifetime prevalence of AUD is 139 and 291 respectively
Only 198 of those with an AUD were ever treated
AUD is significantly associated with MDD bipolar 1 ASPD and borderline PD and also with panic disorder and generalized anxiety disorder
Alcohol leads to approximately 88000 deaths and 25 million years of potential life lost each year in the US
7
Clinical Presentation
Steve presents to clinic for a
routine exam
Steve reports doing well with no
complaints
Steve reports drinking ldquo1-2 drinksrdquo
before bed a few nights each week
Steversquos wife reports that he actually drinks
a fifth of vodka nearly every night
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
6
Alcohol Use Disorder
Centers for Disease Control and Prevention (CDC) Alcohol-Related Disease Impact (ARDI)
Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey
on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1
Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Alcohol use disorder is highly prevalent highly comorbid disabling and often goes untreated
12-month and lifetime prevalence of AUD is 139 and 291 respectively
Only 198 of those with an AUD were ever treated
AUD is significantly associated with MDD bipolar 1 ASPD and borderline PD and also with panic disorder and generalized anxiety disorder
Alcohol leads to approximately 88000 deaths and 25 million years of potential life lost each year in the US
7
Clinical Presentation
Steve presents to clinic for a
routine exam
Steve reports doing well with no
complaints
Steve reports drinking ldquo1-2 drinksrdquo
before bed a few nights each week
Steversquos wife reports that he actually drinks
a fifth of vodka nearly every night
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
7
Clinical Presentation
Steve presents to clinic for a
routine exam
Steve reports doing well with no
complaints
Steve reports drinking ldquo1-2 drinksrdquo
before bed a few nights each week
Steversquos wife reports that he actually drinks
a fifth of vodka nearly every night
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
8
12 oz regular beer (5 alcohol)
bull Light beer contains slightly less alcohol (42)
bull Malt beverages contain approximately 7 alcohol
5 oz of table wine (12 alcohol)
15 oz of 80 proof spirits (40 alcohol)
Remember 60 as an easy way to figure out drink size and percent
Standard Drinks
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
9
Letrsquos Review Measures
1 cup = 8 oz = 53 drinks
1 pint = 2 cups = 16 oz = 106 drinks
1 quart = 2 pints = 32 oz = 213 drinks
1 gallon = 4 quarts = 128 oz = 853 drinks
The above assumes 80 proof spirits
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
10
Nip = common airplane bottle = 50 ml = 17 oz =
slightly more than 1 standard drink
Fifth = fifth of a gallon = 750 ml = 254 oz = 17
standard drinks
Handle = approximately half gallon = 175 L = 59 oz
= 393 standard drinks
Some Other Terms
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
11
Binge drinking = 4 drinks in one sitting for women or 5 for men on at least 1 day in the past month
Heavy alcohol use = binge drinking 5 or more days in the past month
Low risk drinking
bull Women no more than 3 drinks in one sitting or 7 in a week
bull Men no more than 4 drinks on a single day or 14 in a week
More Definitions
Definitions from National Institute on Alcohol Abuse and Alcoholism
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
12
Screening for Alcohol Use Disorder
Screen for risky drinking (gt3 drinks in one sitting or gt7
drinks in one week for women and gt4 drinks in one sitting or
gt14 drinks in one week for men) [criteria previous slide]
CAGE (Cut down Annoyed Guilty Eye opener)
AUDIT-C (Alcohol Use Disorders Identification Test)
bull How often did you have a drink containing alcohol in the
past year
bull How often did you have six or more drinks on one occasion
in the past year
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
13
Legal Intoxication vs Clinical Intoxication
Impact on BAL
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
14
On average one standard drink is metabolized per hour (002)
Hence a BAL of 030 will take approximately 15 hours to metabolize to zero
People with tolerance start to develop withdrawal approximately 6 hours from last drink hence the E in CAGE
Withdrawal will develop long before the BAL reaches 0
Alcohol Metabolism
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
15
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
16
Alcohol withdrawal
bull For most it is not
complicated
bull For some it is deadly
bull We must stratify risk
and triage appropriately
Risk Stratification
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
17
Risk Stratification
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
18
Detox is not treatment
Alcohol withdrawal is an
acute complication of a
chronic medical condition
Treating the acute
complication does not treat
the underlying condition
Most Importantly
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
19
Be aware of standard drink sizes and common terms
Understand the impact on BAL and clinical vs legal
intoxication
Routinely screen all patients for alcohol use disorders
Be able to identify alcohol withdrawal symptoms and
basic treatment strategies
Remember that Detox is not treatment
Alcohol Summary
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
20
Tom is a 61 year old man with an alcohol
use disorder
He was sober and in recovery from
36 ndash 60 years of age
At 60 he was prescribed Xanax for
anxiety
ldquoI did not even know what they gave me As soon as I took it I had a powerful urge to drink alcohol It was as if I had never stopped drinkingrdquo
He relapsed on alcohol and over the past year has struggled
He is now presenting for treatment of alcohol use disorder
Clinical Presentation
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
21
Alprazolam (Xanax) diazepam (Valium)
lorazepam (Ativan) clonazepam
(Klonopin) chlordiazepoxide (Librium)
and temazepam (Restoril) are the most
common
Indicated and useful for anxiety and
insomnia if properly monitored though
not considered first line for either
Pharmacologic overlap with alcohol
Benzodiazepines
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
22
Benzodiazepines (continued)
Do not fly the plane unless you know how to land
ldquoBarsrdquo = Xanax 2 mg
Can cause overdose death when mixed with opioids or alcohol
Often mixed with alcohol to magnify the high
Withdrawal can be protracted and dangerous
Common cause of falls and delirium in elderly
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
23
ldquoWhen I start to run out I begin crawling
around on the carpet looking for any
little bit I can find
Then I look around and think every car
car outside is the police and they
are after me
Then I look in the mirror my eyes are bloodshot and my heart is racing I feel awful and paranoid
Then I say to myself that I will NEVER do this again
Then I do it again the next dayrdquo
Clinical Presentation
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
24
Dopamine reuptake inhibitor
Leads to supraphysiologic dopamine release
Crack is mixed with a base smoked and is
highly addictive
Was widely used recreationally prior to 1914
including mixed with alcohol (Vin Mariani)
Snorting 146 minutes to peak
Injecting 31 minutes to peak
Smoking 14 minutes to peak
Cocaine
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
25
ldquoWoe to you my princess when I come I will
kiss you quite red and feed you til you are
plump And if you are forward you shall
see who is the stronger a gentle little girl
who doesnrsquot eat enough or a big wild man
who has cocaine in his body In my last
depression I took coca again and a small
dose lifted me to the heights in a wonderful
fashion I am just now busy collecting
literature for a song of praise to this magical
substancerdquo
Cocaine
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
26
Acute
bull Pleasure alertness energy sexuality tachycardia hallucinations paranoia hypertension
Crash
bull Peaks 2-4 days but up to a week of prolonged dysthymia hypersomnolence irritability suicidality cravings
Chronic
bull Profound anhedonia and other long term consequences dependent on route of admin
Cocaine
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
27
Chris is a 40-year old male who presents
to clinic seeking help with anxiety He reports
chronic anxiety with worry and ruminations
He also reports occasional panic attacks
He has tried SSRIs in the past with minimal
improvement He is currently smoking
marijuana daily and states that it is the only
thing that helps
He is willing to try a new medication but unwilling to stop smoking marijuana
Clinical Presentation
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
28
ldquoMarijuanardquo is the term for the plant Cannabis
THC = Tetrahydrocannabinol = psychoactive
CBD = Cannabidiol = sedating not psychoactive
Sativa and Indica differ in THCCBD ratio
Marijuana the herb is generally dried flowers
Hashish is a resin with higher THC levels and generally heated in a pipe or eaten
Hash oil is the most potent and can be smoked ingested or used topically
Marijuana
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
29
Joint marijuana rolled in paper
Fatty larger amount of marijuana
Doobie rolled with king size paper
Blunt Rolled with cigar wrapper and contains tobacco
Pipes (also known as bowls) are usually glass and rarely have a filter
Bongs contain water filter
Marijuana
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
30
Marijuana Legal Status
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
31
Marijuana Effects
Acute Intoxication
bull Improved mood increased well-being calmness relaxation
and sociability
bull Increased self-confidence magical thinking distorted
perception of time and space increased sensory perception
bull Tachycardia palpitations vasodilation conjunctival
irritation dry mouth increased appetite
bull Anxiety panic confusion hallucinations paranoia
psychosis
Withdrawal
bull Anxiety depression mood changes GI distress decreased
appetite insomnia irritability
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
32
First Illicit Drug Used
Figure from SAMHSA
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
33
Marijuana
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
34
ldquoIt bothers me that people are so stupid as to use
this stuffrdquo ndash John W Huffman developer
Sprayed on dried plant material or inhaled in
vaporizer
Marketed as ldquonot for human consumptionrdquo and were
sold legally under hundreds of brands most notably
K2 and Spice
Synthetic Cannabinoids
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
35
False belief that these are ldquonaturalrdquo and thus harmless
They are also not detected in routine drug screens
Acute effects are very unpredictable and generally
less pleasant than natural cannabis
Psychotic symptoms include extreme anxiety
confusion paranoia and hallucinations
Synthetic Cannabinoids
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
36
Mike is a 23 year old who presents
to the ER with paranoia
He reports holding a loaded gun
and pointing it at people outside of his
window thinking they were all trying
to kill him
He previously used meth heavily but has recently cut down
His last use was 3 days ago
Clinical Presentation
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
37
Janice is a 36 year old female who presented to the ER seeking
help with methamphetamine addiction
She appears older than stated age and is very thin
She has several missing teeth and otherwise poor
dentition
Her skin has multiple lesions
ldquoWhen I first starting smoking ice it felt so good Now it no longer feels like that
I do not even get much pleasure out of it any more I do not get pleasure out
of anything anymore I have no desire to see family or friends or do the things
I used to love I wish I could have fun like I used tordquo
Clinical Presentation
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
38
Crystal Ice Glass
Leads to an acute increase in synaptic dopamine concentration through various mechanisms
Can be prescribed as Desoxyn for
ADHD
Prominent in the western region of US and made famous by Breaking Bad
television series
Many accidents and fires are associated
with ldquobackyardrdquo meth labs
Methamphetamine
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
39
Mental illness and co-morbid or co-occurring substance use disorder is common
Approximately 13 of all people with mental illness and 12 with severe mental illness also have a substance use disorder
Self medication hypothesis vs substance
induced disorder
Multi-modal parallel or integrated treatment approach is most effective
Dual Diagnosis
Data from SAMHSA
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
40
Toxicology Screening
Urine most common method given cost and ease of collection Problem adulteration and substitution
bull On-site rapid testing
bull Immunoassay (initial lab screen)
bull GCMS
Blood better for quantitative analysis detection of acute intoxication Problem invasive detection for shorter periods than urine
Saliva Non-invasive lower potential for adulteration than urine Problem higher detection threshold and greater cost
Sweat Can identify substances over longer period of time Problem difficult to collect and quantify
Hair Easy to collect less likelihood of adulteration provides qualitative account of history of ingestion Problem poor at detecting acute intoxication more labor-intensive to process
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
41
Screening for drugs in healthy individuals
with no prior suspicion
bull Workplace or athletic testing
Testing for drugs in ill persons with a prior suspicion of use
Monitoring for drugs as part of a pain management or treatment program
While reliable on-site urine drug testing offers preliminary results When making treatment altering decisions urine should always be sent for confirmatory testing
Urine Testing
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
42
Urine Detection Limits
Alcohol 6 - 12 hours
EtG (ethylglucuronide) 4 days
Amphetaminesmeth 2 - 3 days
Benzos (short-acting) 3 days
Cocaine 3 - 4 days
Morphine 2 days
Marijuana (THC) 3 - 30+ days
Methadone 2 - 4 days
Buprenorphine 2 - 4 days
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
Adapted from Helander et al 2009 Moeller et al 2008
NIDA Neurobio of Addiction (2016 In Addiction Assessment and Treatment
Levounis Zerbo and Aggarwal Eds
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
43
Urine Drug Testing Stimulants
Amphetamine Methamphetamine
bull False positives pseudoephedrine bupropion labetolol ranitidine trazodone TCAs
bull Low sensitivity for detection of MDMA
bull 2 methamphetamine isomers d (CNS) and l (peripheral)
Cocaine
bull Primary metabolite benzoyleconine
bull False positives rare (coca leaf tea adulterated natural products)
Opiates
bull Tests for morphine-based substances
bull Unreliable for synthetic opioids like oxycodone
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
44
Summary
Alcohol use disorder is a common and deadly illness
with significant comorbidities
Alcohol withdrawal management does not treat AUD
It is important to understand key concepts in other
drug use disorders
Urine drug testing is an important piece to clinical
decision making
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
45
References
Disease ImCenters for Disease Control and Prevention (CDC) Alcohol-Related pact (ARDI) Atlanta GA CDC
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III Grant BF1 Goldstein RB1 Saha TD1 Chou SP1 Jung J1 Zhang H1 Pickering RP1 Ruan WJ1 Smith SM1 Huang B1 Hasin DS2
Levounis amp Lynch DSM-5 Diagnosis and Toxicology (2016) In Addiction Assessment and Treatment Levounis Zerbo and Aggarwal Eds
Stahre M Roeber J Kanny D Brewer RD Zhang X Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States Prev Chronic Dis 201411130293
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
46
PCSS-MAT Mentoring Program
PCSS-MAT Mentor Program is designed to offer general information to
clinicians about evidence-based clinical practices in prescribing
medications for opioid addiction
PCSS-MAT Mentors are a national network of providers with expertise in
medication-assisted treatment and addictions
3-tiered approach allows every mentormentee relationship to be unique
and catered to the specific needs of the mentee
No cost
For more information visit
pcssmatorgmentoring
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
47
PCSS Discussion Forum
Have a clinical question
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
48
Funding for this initiative was made possible (in part) by grant no 1U79TI026556-01 from SAMHSA The views expressed in written
conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department
of Health and Human Services nor does mention of trade names commercial practices or organizations imply endorsement by the
US Government
PCSS-MAT is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in
partnership with the Addiction Technology Transfer Center (ATTC) American Academy of Family
Physicians (AAFP) American Academy of Pain Medicine (AAPM) American Academy of Pediatrics
(AAP) American College of Emergency Physicians (ACEP) American College of Physicians (ACP)
American Dental Association (ADA) American Medical Association (AMA) American Osteopathic
Academy of Addiction Medicine (AOAAM) American Psychiatric Association (APA) American
Psychiatric Nurses Association (APNA) American Society of Addiction Medicine (ASAM) American
Society for Pain Management Nursing (ASPMN) Association for Medical Education and Research in
Substance Abuse (AMERSA) International Nurses Society on Addictions (IntNSA) National
Association of Community Health Centers (NACHC) and the National Association of Drug Court
Professionals (NADCP)
For more information wwwpcssmatorg
Twitter PCSSProjects
49
PCSS-MAT Training Mentoring Resources
49
PCSS-MAT Training Mentoring Resources